Etcembly Appoints Scott Cuthill as Chief Business Officer
Etcembly Appoints Scott Cuthill as Chief Business Officer. The Oxford based company is transforming TCR immunotherapy research.
top of page
![E3353_06 [ALT4ax].png](https://static.wixstatic.com/media/73af19_3c2aa92876234a68b46bead64acb0ce5~mv2.png/v1/fill/w_957,h_947,al_c,q_90,usm_0.66_1.00_0.01,enc_auto/73af19_3c2aa92876234a68b46bead64acb0ce5~mv2.png)
Feb 7, 2022
Research Complex at Harwell welcomes Etcembly
Research Complex at Harwell is delighted to welcome Etcembly. The company is continuing to expand to realise its goal to assemble the...
423 views
Feb 7, 2022
Etcembly establishes new lab & office space at Oxford Science Park
Immune-focused machine learning firm joins leading AI cohort on Park Etcembly Ltd has moved into more than 1,000 square feet of new...
325 views
Feb 7, 2022
Zelluna Immunotherapy AS Announces Exclusive Research Collaboration with Etcembly Limited
Oslo, Norway and Oxford, UK: 29th April 2021. Zelluna Immunotherapy AS announces an exclusive research collaboration with Etcembly Ltd to...
340 views
Feb 7, 2022
Oxford-based machine learning start-up Etcembly secures Private Seed Funding
Oxford, UK: 23rd April 2021. No embargo. Etcembly Ltd (Etcembly), a company building a platform to decode immune repertoires in health...
791 views
bottom of page